Vanguard Capital Management’s SELLAS Life Sciences SLS Stock Holding History
Bought
Maintained
Sold
Other funds holding SLS
Vanguard Capital Management's SLS Position: Q3 2026 in Review
Vanguard Capital Management increased its SELLAS Life Sciences (SLS) stake by 8.7% in Q3 2026, buying an estimated $8.98M and bringing the position to 8,942,647 shares worth $110M. The position accounts for ﹤0.01% of the portfolio, ranked #1469.
Vanguard Capital Management first reported a position in SLS in Q1 2026 and has held it in 3 quarters since. The position peaked at $121M in Q2 2026. 217 funds tracked by Wall St. Rank hold SLS as of Q3 2026.
- Vanguard Capital Management held 8,942,647 shares of SELLAS Life Sciences worth $110M as of Q3 2026.
- Vanguard Capital Management bought 716,542 SELLAS Life Sciences shares in Q3 2026, an estimated $8.98M.
- SELLAS Life Sciences made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1469 holding.
- Vanguard Capital Management first reported a position in SELLAS Life Sciences in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's SELLAS Life Sciences position peaked at $121M in Q2 2026.
- 217 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.